Abstract
Psychotropic drugs are probably the most common form of treatment for anxiety and anxiety disorders. However, they are not necessarily the most effective treatment for anxiety disorders. Their extensive use is due, in part, to the fact that one of the first places people go for help with anxiety problems is to their family physician. Most of the psychotherapeutic drug prescriptions are written by nonpsychiatric physicians who are not trained in the treatment procedures described in the previous two chapters, nor do they have the time to devote to the treatment of anxiety disorders. Many of these drugs provide rapid relief from anxiety and are useful and effective as a first step to dealing with anxiety and stress responses. Since they often relieve anxiety, the person may look no further for other treatments. These drugs, together with psychologically based treatments described previously, provide a wide array of treatment alternatives to those individuals who are suffering from anxiety, fear, and panic disorders.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Barry Blackwell, “Psychotropic Drugs in Use Today: The Role of Diazepam in Medical Procedure,” Journal of the American Medical Association 125 (1973): 1637–1641.
Marvin E. Licky and Barbara Gordon, Drugs for Mental Illness: A Revolution in Psychiatry ( New York: W. H. Freeman, (1983).
Karl Rickels, R. W. Downing, and A. Winoker, “Antianxiety Drugs: Clinical Use in Psychiatry,” in Handbook of Psychopharmacology: Vol. 13, Biology of Mood and Antianxiety Drugs, L. L. Iverson, S. D. Iverson, and S. H. Snyder, ed. ( New York: Plenum, 1978 ), 395–430.
Donald Klein, Rachel Gittelman, F. Quitkin, and A. Rifkin, Diagnosis and Drug Treatment of Psychiatric Disorders: Adults and Children, 2nd ed. ( Baltimore: Williams Wilkins, 1980 ).
D. J. Greenblatt and R. I. Shader, Benzodiazepines in Clinical Practice ( New York: Raven Press, 1972 ).
Klein et al., Diagnosis and Drug Treatment.
Rickels et al., “Antianxiety Drugs,” 395–430.
Ibid.
Klein et al., Diagnosis and Drug Treatment.
Russell Noyes, Jr., D. J. Anderson, J. Clancy, Raymond Crowe, D. J. Slyman, M. M. Ghonein, and J. V. Hinrichs, “Diazepam and Propranolol in Panic Disorder and Agoraphobia,” Archives of General Psychiatry, 41 (1984): 287–292.
G. Chauinard, L. Annable, R. Fontaine, and L. Solyom, “Alprazolam in the Treatment of Generalized Anxiety and Panic Disorders: A Double-Blind Placebo-Controlled Study,” Psychopharmacology 77 (1982): 229–233.
James Ballenger, G. Burrows, R. DuPont, I. Lesser, R. Noyes, J. Pecknold, A. Riskin, and R. Swanson, “Alprazolam in Panic Disorder: Results from a Multicenter Trial: 1. Efficacy in Short Term Treatment,” Archives of General Psychiatry 45 (1988): 413–422.
Joseph Wolpe, The Practice of Behavior Therapy (Oxford, England: Pergamon Press, 1973 ).
Marvin E. Licky, and Barbara Gordon, Drugs for Mental Illness: A Revolution in Psychiatry ( New York: W. H. Freeman, (1983).
Ronald Kleinknecht and David Donaldson, “A Review of the Effects of Diazepam on Cognitive and Psychomotor Performance,” Journal of Nervous and Mental Disease 161 (1975): 399–411.
R. Fontaine, L. Annable, P. Deaudry, P. Mercier, and G. Chouinard, “Efficacy and Withdrawal of Two Potent Benzodiabepines: Bromazepam and Lorazepam,” Psychopharmacology Bulletin 21 (1985): 91–92.
M. Dhyanne Warner, Cecilia Peabody, Nashaat Boutros, and Harvey Whiteford, “Alprazolam and Withdrawal Seizures,” Journal of Nervous and Mental Disease 178 (1990): 208–209.
Truman Schnable, Jr., “Evaluation of the Safety and Side Effect of Anxiety Agents,” American Journal of Medicine 82 (Supplement 5A, 1987 ): 7–13.
Malcolm Lader, “Assessing the Potential for Buspirone Dependence or Abuse and Effects of Its Withdrawal,” American Journal of Medicine 82 (Supplement 5A, 1987): 20–26.
Donald Klein, Donald Ross, and Patricia Cohen, “Panic and Avoidance in Agoraphobia: Application of Path Analysis to Treatment Studies,” Archives of General Psychiatry 44 (1987): 377–385.
Desmond Kelly, Anxiety and Emotions: Physiological Basis and Treatment, ( Springfield, Ill.: Charles Thomas, 1980 ).
Janet Klosko, David Barlow, R. B. Tassinari, and Jerome Cerny, “A Comparison of Alprazolam and Cognitive-Behavior Therapy in Treatment of Panic Disorder,” Journal of Consulting and Clinical Psychology 58 (1990): 77–84.
CIBA-GEIGY Corporation (Summit, New Jersey, 1990).
Isaac Marks, Gray, D. Cohen, R. Hill, D. Mawson, E. Ramm, and Richard Stern, “Imipramine and Brief Therapist Aided Exposure in Agoraphobics Having Self-Exposure Homework,” Archives of General Psychiatry 40 (1983): 153–162.
Richard Stern and Isaac Marks, “Brief and Prolonged Flooding: A Comparison in Agoraphobic Patients,” Archives of General Psychiatry 28 (1973): 270–276.
Desmond Kelly, Anxiety and Emotions: Physiological Basis and Treatment, ( Springfield, Ill.: Charles Thomas, 1980 ).
Charlotte Zitrin, “Differential Treatment of Phobias: Use of Imipramine for Panic Attacks,” Journal of Behavior Therapy and Experimental Psychiatry 14 (1983): 11–18.
David Sheehan, James Ballenger, and G. Jacobsen, “Treatment of Endogenous Anxiety with Phobic, Hysterical and Hypochondriacal Symptoms,” Archives of General Psychiatry 37 (1980): 51–59.
Zitrin, “Differential Treatment,” 11–18.
David Barlow, Anxiety and Its Disorders, ( New York: Guilford Press, 1988 ).
Zitrin, “Differential Treatment,” 11–18.
Russell Noyes, Jr., D. J. Anderson, J. Clancy, R. R. Crowe, D. J. Slyman, M. M. Ghonein, and J. V. Hinrichs, “Diazepam and Propranolol in Panic Disorder and Agoraphobia,” Archives of General Psychiatry 41 (1984): 287–292.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media New York
About this chapter
Cite this chapter
Kleinknecht, R.A. (1991). Drug Treatment of Anxiety Disorders. In: Mastering Anxiety. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-7319-1_10
Download citation
DOI: https://doi.org/10.1007/978-1-4899-7319-1_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-43769-4
Online ISBN: 978-1-4899-7319-1
eBook Packages: Springer Book Archive